Blood test could tell doctors when to stop antiviral drugs
NCT ID NCT06668025
Summary
This small pilot study tested whether using a blood marker called MxA to guide when to stop antiviral treatment could improve outcomes for adults with flu or COVID-19. Researchers compared this new approach to standard care to see if it reduced the chance of the infection coming back within 30 days. The goal was to find a more personalized way to manage treatment, potentially avoiding giving medicine for too long or not long enough.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China-Japan Friendship hospital
Beijing, Beijing Municipality, 100029, China
Conditions
Explore the condition pages connected to this study.